Ruscogenin	B:C0073709
Attenuates	O
Cerebral	B:C0917798
Ischemia	I:C0917798
-	O
Induced	O
Blood	B:C0005854
-	I:C0005854
Brain	I:C0005854
Barrier	I:C0005854
Dysfunction	O
by	O
Suppressing	O
thiredoxin-	B:C1448239
interactive	I:C1448239
protein	I:C1448239
/	O
NLRP3	B:C3272080
Inflammasome	I:C3272080
Activation	I:C3272080
and	O
the	O
MAPK	B:C1518102
Pathway	I:C1518102
.	O

Ruscogenin	B:C0073709
,	O
an	O
important	O
steroid	B:C0038317
sapogenin	B:C0072845
derived	O
from	O
Ophiopogon	B:C1046253
japonicus	I:C1046253
,	O
has	O
been	O
shown	O
to	O
inhibit	O
cerebral	O
ischemic	O
injury	O
.	O

However	O
,	O
its	O
potential	O
molecular	B:C1148560
action	I:C1148560
on	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
(	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
)	O
dysfunction	O
after	O
stroke	B:C0038454
remains	O
unclear	O
.	O

This	O
study	B:C2603343
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
ruscogenin	B:C0073709
on	O
blood	B:C0005854
-	I:C0005854
brain	I:C0005854
barrier	I:C0005854
dysfunction	O
and	O
the	O
underlying	O
mechanisms	O
in	O
middle	B:C0740391
cerebral	I:C0740391
artery	I:C0740391
occlusion	I:C0740391
/	O
reperfusion	B:C3854511
(	O
MCAO	B:C0740391
/	O
R	B:C3854511
)	O
-	O
injured	O
mice	B:C0026809
and	O
oxygen	B:C4236781
-	I:C4236781
glucose	I:C4236781
deprivation	I:C4236781
/	O
reoxygenation	O
(	O
OGD	B:C4236781
/	O
R	O
)	O
-	O
injured	O
mouse	B:C0026809
brain	B:C0006104
microvascular	O
endothelial	B:C0225336
cells	I:C0225336
(	O
bEnd.3	B:C0225336
)	O
.	O

The	O
results	O
demonstrated	O
that	O
administration	B:C1533734
of	O
ruscogenin	B:C0073709
(	O
10	O
mg	O
/	O
kg	O
)	O
decreased	O
the	O
brain	B:C0751955
infarction	I:C0751955
and	O
edema	B:C0013604
,	O
improved	B:C0184511
neurological	B:C0521654
deficits	I:C0521654
,	O
increased	O
cerebral	B:C0428714
brain	I:C0428714
flow	I:C0428714
(	O
cerebral	B:C0428714
brain	I:C0428714
flow	I:C0428714
)	O
,	O
ameliorated	B:C0184511
histopathological	O
damage	B:C0010957
,	O
reduced	O
evans	B:C0015205
blue	I:C0015205
(	O
evans	B:C0015205
blue	I:C0015205
)	O
leakage	B:C4281748
and	O
upregulated	B:C0041904
the	O
expression	B:C1171362
of	O
tight	B:C3494363
junctions	I:C3494363
(	O
tight	B:C3494363
junctions	I:C3494363
)	O
in	O
MCAO	B:C0740391
/	O
R	B:C3854511
-	O
injured	O
mice	B:C0026809
.	O

Meanwhile	O
,	O
ruscogenin	B:C0073709
(	O
0.1	O
-	O
10	O
µ	O
M	O
)	O
treatment	B:C0087111
increased	O
cell	B:C0007620
viability	I:C0007620
and	O
trans	O
-	O
endothelial	O
electrical	O
resistance	O
(	O
TEER	O
)	O
value	O
,	O
decreased	O
sodium	B:C0147866
fluorescein	I:C0147866
leakage	B:C4281748
,	O
and	O
modulated	B:C0443264
the	O
tight	B:C3494363
junctions	I:C3494363
expression	B:C1171362
in	O
OGD	B:C4236781
/	O
R	O
-	O
induced	O
bEnd.3	B:C0225336
cells	I:C0225336
.	O

Moreover	O
,	O
ruscogenin	B:C0073709
also	O
inhibited	O
the	O
expression	B:C1171362
of	O
interleukin	B:C0021753
-	I:C0021753
1β	I:C0021753
(	O
interleukin	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
)	O
and	O
caspase	B:C0534519
-	I:C0534519
1	I:C0534519
,	O
and	O
markedly	O
suppressed	O
the	O
expression	B:C1171362
of	O
Nucleotide	B:C4255055
-	I:C4255055
binding	I:C4255055
domain	I:C4255055
(	I:C4255055
NOD	I:C4255055
)	I:C4255055
-	I:C4255055
like	I:C4255055
receptor	I:C4255055
family	I:C4255055
,	I:C4255055
pyrin	I:C4255055
domain	I:C4255055
containing	I:C4255055
3	I:C4255055
(	O
NLRP3	B:C1528260
)	O
and	O
thiredoxin	B:C1448239
-	I:C1448239
interactive	I:C1448239
protein	I:C1448239
(	O
thiredoxin	B:C1448239
-	I:C1448239
interactive	I:C1448239
protein	I:C1448239
)	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Furthermore	O
,	O
ruscogenin	B:C0073709
decreased	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
generation	O
and	O
inhibited	O
the	O
mitogen	B:C1518102
-	I:C1518102
activated	I:C1518102
protein	I:C1518102
kinase	I:C1518102
(	I:C1518102
MAPK	I:C1518102
)	I:C1518102
pathway	I:C1518102
in	O
OGD	B:C4236781
/	O
R	O
-	O
induced	O
bEnd.3	B:C0225336
cells	I:C0225336
.	O

Our	O
findings	B:C0243095
provide	O
some	O
new	O
insights	B:C0233820
into	O
its	O
potential	O
application	B:C0185125
for	O
the	O
prevention	B:C0199176
and	O
treatment	B:C0087111
of	O
ischemic	B:C0948008
stroke	I:C0948008
.	O

